CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound. The company’s CoapTech Carrier™ is a novel platform technology combining magnetic attraction for device placement guidance and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures.

CoapTech is commercializing a kit that will enable clinicians to perform a novel procedural method called Percutaneous Ultrasound Gastrostomy (PUG) for the placement of semi-permanent feeding tubes in the stomach. PUG improves on Percutaneous Endoscopic Gastrostomy (PEG), the current standard of care for feeding tube placement. The company believes that PUG is a safer, simpler, and less expensive method for placing feeding tubes.

N5 Sensors, a University of Maryland spin-off founded by UMD Research Scientist Abhishek Motayed, is commercializing a new generation of chip-scale chemical sensors that can detect harmful chemicals mixed in air, such as industrial chemicals, automobile exhausts, cigarette smoke, and pollutants released from paints, cleaners, pesticides and other products. These new sensors, built using the same fabrication processes that are commonly used for silicon computer chips, are small and accurate, with the capability to detect multiple gases at the same time. N5 is working to develop arrays of multi analyte sensors on a single chip, which can be integrated with smart phones, allowing industrial workers, first-responders, and soldiers to assess the dangers of their surroundings rapidly and accurately in real-time using their smart phones.

Vasoptic Medical Inc. is a medical device company developing and commercializing high-quality, cost-effective products for the non invasive, dynamic assessment of retinal blood flow and vascular status. Vasoptic Medical has developed a low-cost, portable, noninvasive retinal imaging instrument (the XyCAM), which can complement fundus photographs with retinal blood flow information obtained at high spatio-temporal resolution without the introduction of any dyes. This handheld retinal imager has the potential to help detect a number of clinical conditions, including diabetic retinopathy (DR), glaucoma, and age-related macular degeneration. Early detection can often prevent vision loss. The XyCAM device is being designed to detect these conditions inn their earliest stages to help healthcare providers manage and prevent DR and glaucoma progression through a convenient, low-cost, minimally invasive procedure.

Northrop Grumman Corporation offers an extraordinary portfolio of capabilities and technologies that enable the company to deliver innovative systems and solutions for applications that range from undersea to outer space and into cyberspace.

The company’s core competencies address emerging global security challenges in key areas, such as unmanned systems, cybersecurity, C4ISR, and logistics that are critical to the defense of the nation and its allies.